333

MEDPRIN REGENERATI

No trades
See on Supercharts
Market capitalization
‪2.23 B‬CNY
‪40.88 M‬CNY
‪226.30 M‬CNY
Beta (1Y)
1.59

About MEDPRIN REGENERATI

CEO
Yu Yu Yuan
Headquarters
Guangzhou
Employees (FY)
278
Founded
2008
ISIN
CNE100004NB8
FIGI
BBG00W043YB0
Medprin Regenerative Medical Technologies Co. Ltd. engages in the development of implanted medical devices. Its product specializes in using advanced manufacturing technology in combination with the characteristics of artificial synthetic materials. The firm's neurosurgery implanted medical device products include artificial dural (spine) membrane patch, cranio-maxillofacial repair products, and absorbable hemostatic gauze. The company was founded on September 2, 2008 and is headquartered in Guangzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 301033 is 33.71 CNY — it has decreased by 0.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange MEDPRIN REGENERATI stocks are traded under the ticker 301033.
301033 stock is 4.89% volatile and has beta coefficient of 1.59. Check out the list of the most volatile stocks — is MEDPRIN REGENERATI there?
Yes, you can track MEDPRIN REGENERATI financials in yearly and quarterly reports right on TradingView.
301033 stock has risen by 17.25% compared to the previous week, the month change is a 3.08% fall, over the last year MEDPRIN REGENERATI has showed a 19.20% decrease.
301033 net income for the last quarter is ‪15.45 M‬ CNY, while the quarter before that showed ‪13.53 M‬ CNY of net income which accounts for 14.18% change. Track more MEDPRIN REGENERATI financial stats to get the full picture.
Today MEDPRIN REGENERATI has the market capitalization of ‪2.23 B‬, it has decreased by 0.26% over the last week.
Yes, 301033 dividends are paid annually. The last dividend per share was 0.20 CNY. As of today, Dividend Yield (TTM)% is 0.59%. Tracking MEDPRIN REGENERATI dividends might help you take more informed decisions.
MEDPRIN REGENERATI dividend yield was 0.92% in 2023, and payout ratio reached 64.64%. The year before the numbers were 0.54% and 36.81% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 301033 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDPRIN REGENERATI stock right from TradingView charts — choose your broker and connect to your account.
301033 reached its all-time high on Jul 26, 2021 with the price of 85.57 CNY, and its all-time low was 22.37 CNY and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 278.00 employees. See our rating of the largest employees — is MEDPRIN REGENERATI on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDPRIN REGENERATI technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDPRIN REGENERATI stock shows the sell signal. See more of MEDPRIN REGENERATI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDPRIN REGENERATI EBITDA is ‪68.29 M‬ CNY, and current EBITDA margin is 30.30%. See more stats in MEDPRIN REGENERATI financial statements.